Kezar Life Sciences Inc (KZR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Operating Expenses | 15,878 | 14,103 | 14,499 | 13,009 | 13,048 |
| Operating Income | -15,878 | -14,103 | -14,499 | -13,009 | -13,048 |
| Interest Expense | 254 | 0 | 0 | 0 | 0 |
| Other Income | 108 | -109 | 37 | 47 | 54 |
| Pre-tax Income | -16,024 | -14,212 | -14,462 | -12,962 | -12,994 |
| Net Income Continuous | -16,024 | -14,212 | -14,462 | -12,962 | -12,994 |
| Net Income | $-16,024 | $-14,212 | $-14,462 | $-12,962 | $-12,994 |
| EPS Basic Total Ops | -2.60 | -2.60 | -2.80 | -2.50 | -2.50 |
| EPS Basic Continuous Ops | -2.64 | -2.53 | -2.78 | -2.50 | -2.54 |
| EPS Diluted Total Ops | -2.60 | -2.60 | -2.80 | -2.50 | -2.50 |
| EPS Diluted Continuous Ops | -2.64 | -2.53 | -2.78 | -2.50 | -2.54 |
| EBITDA(a) | $-15,069 | $-13,308 | $-13,713 | $-12,105 | $-12,162 |